Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8174730 | 0.99 | TSHR (0.33) | TSHRHPGDALDH1A1TP53HIF1A | |
| Acetic Acid SCHEMBL8189714 | 0.96 | TSHR (0.31) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL7110490 | 0.86 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL7111765 | 0.86 | GSTP1 (0.33) | — | |
| SCHEMBL7109743 | 0.84 | TSHR (0.33) | TSHRHPGDATM | |
| SCHEMBL8776584 | 0.71 | TSHR (0.38) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL7111886 | 0.70 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL2391518 | 0.68 | TSHR (0.35) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL238971 | 0.67 | TSHR (0.43) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL13968333 | 0.67 | TSHR (0.37) | TSHRHPGDALDH1A1TP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8017665-B2 | Ophthalmic devices containing heterocyclic compounds and methods for their production | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2011-09-13 | — | — | US | claimed |
| US-7173073-B2 | Ophthalmic devices containing heterocyclic compounds and methods for their production | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2007-02-06 | — | — | US | claimed |
| EP-1327893-B1 | Ophthalmic devices containing heterocyclic compounds and methods for their production | JOHNSON & JOHNSON VISION CARE (US) | 2006-07-12 | — | — | EP | claimed |
| US-20030139490-A1 | Ophthalmic devices containing heterocyclic compounds and methods for their production | JOHNSON & JOHNSON VISION CARE, INC. | 2003-07-24 | — | — | US | claimed |
| WO-2003060572-A1 | OPHTHALMIC DEVICES CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2003-07-24 | — | — | WO | claimed |
| EP-1327893-A1 | Ophthalmic devices containing heterocyclic compounds and methods for their production | Johnson & Johnson Vision Care, Inc. (US) | 2003-07-16 | — | — | EP | claimed |
| US-6162452-A | Surface active N-halamine compounds | AUBURN UNIVERSITY (US) | 2000-12-19 | — | — | US | claimed |
| WO-1999029678-A1 | MONOMERIC AND POLYMERIC SURFACE ACTIVE BIOCIDAL N-HALO-OXAZOLIDINONES | AUBURN UNIVERSITY (US) | 1999-06-17 | — | — | WO | claimed |
| US-5902818-A | N-HALOGENATED, OXAZOLIDINONE MONOMERS HAVING AN ACRYLIC ESTER GROUP AT THE 4-POSITION RELEASE SMALL AMOUNTS FREE HALOGENS; DISINFECTANTS SUCH AS MEDICAL AND DENTAL COATINGS, FABRICS; COST EFFICIENCY, PERFORMANCE | AUBURN UNIVERSITY (US) | 1999-05-11 | — | — | US | claimed |
| US-8017665-B2 | Ophthalmic devices containing heterocyclic compounds and methods for their production | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2011-09-13 | — | — | US | disclosed |
| US-20100238399-A1 | OPHTHALMIC DEVICES CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION | JOHNSON & JOHNSON VISION CARE, INC. | 2010-09-23 | — | — | US | disclosed |
| US-7767730-B2 | Ophthalmic devices containing heterocyclic compounds and methods for their production | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2010-08-03 | — | — | US | disclosed |
| US-20070155852-A1 | OPHTHALMIC DEVICES CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION | JOHNSON & JOHNSON VISION CARE, INC. | 2007-07-05 | — | — | US | disclosed |
| US-7173073-B2 | Ophthalmic devices containing heterocyclic compounds and methods for their production | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2007-02-06 | — | — | US | disclosed |
| US-20030064051-A1 | Surface active N-halamine compounds | AUBURN UNIVERSITY | 2003-04-03 | — | — | US | disclosed |
| US-20030044376-A1 | Surface active N-halamine compounds | AUBURN UNIVERSITY | 2003-03-06 | — | — | US | disclosed |
| US-6469177-B1 | CYCLIC N-HALAMINES THAT ARE BIOCIDAL WHEN THEY COME IN CONTACT WITH HALOGEN-SENSITIVE ORGANISMS; ACHIEVED BY COATING THE N-HALAMINE ON A SUBSTRATE | AUBURN UNIVERSITY | 2002-10-22 | — | — | US | disclosed |
| US-6162452-A | Surface active N-halamine compounds | AUBURN UNIVERSITY (US) | 2000-12-19 | — | — | US | disclosed |
| WO-1999029678-A1 | MONOMERIC AND POLYMERIC SURFACE ACTIVE BIOCIDAL N-HALO-OXAZOLIDINONES | AUBURN UNIVERSITY (US) | 1999-06-17 | — | — | WO | disclosed |
| US-5902818-A | N-HALOGENATED, OXAZOLIDINONE MONOMERS HAVING AN ACRYLIC ESTER GROUP AT THE 4-POSITION RELEASE SMALL AMOUNTS FREE HALOGENS; DISINFECTANTS SUCH AS MEDICAL AND DENTAL COATINGS, FABRICS; COST EFFICIENCY, PERFORMANCE | AUBURN UNIVERSITY (US) | 1999-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030044376-A1 | Surface active N-halamine compounds | AAAS, HNMT, LTN1 | TSHR 1696/4885HPGD 466/4885ALDH1A1 1576/4885 |
| US-20030064051-A1 | Surface active N-halamine compounds | AAAS, HNMT, LTN1 | TSHR 1696/4885HPGD 466/4885ALDH1A1 1576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.